146 related articles for article (PubMed ID: 24959213)
1. High expression of erythropoietin-producing hepatoma cell line-B2 (EphB2) predicts the efficiency of the Qingyihuaji formula treatment in pancreatic cancer CFPAC-1 cells through the EphrinB1-EphB2 pathway.
Hua YQ; Chen Z; Meng ZQ; Chen H; Shen JG; Wang K; Peng W; Shen YH; Liu LM
Oncol Lett; 2014 Jul; 8(1):17-24. PubMed ID: 24959213
[TBL] [Abstract][Full Text] [Related]
2. Qingyihuaji formula reverses gemcitabine resistant human pancreatic cancer through regulate lncRNA AB209630/miR-373/EphB2-NANOG signals.
Chen P; Wang M; Wang C
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31147453
[TBL] [Abstract][Full Text] [Related]
3. Promoted cancer growth by stimulating cell proliferation and decreasing apoptosis using a lentivirus-based EphB2 RNAi in pancreatic carcinoma CFPAC-1 cells.
Hua YQ; Ouyang HQ; Chen Z; Meng ZQ; Luo JM; Lin JH; Zhou ZH; Chen H; Wang K; Liu LM
Biomed Pharmacother; 2011 Mar; 65(2):123-31. PubMed ID: 21292437
[TBL] [Abstract][Full Text] [Related]
4. Ski acts as therapeutic target of qingyihuaji formula in the treatment of SW1990 pancreatic cancer.
Wang P; Chen Z; Meng ZQ; Luo JM; Lin JH; Zhou ZH; Chen H; Wang K; Shen YH; Liu LM
Integr Cancer Ther; 2010 Mar; 9(1):50-8. PubMed ID: 20308085
[TBL] [Abstract][Full Text] [Related]
5. Qingyihuaji formula inhibits progress of liver metastases from advanced pancreatic cancer xenograft by targeting to decrease expression of Cyr61 and VEGF.
Yin JH; Shi WD; Zhu XY; Chen Z; Liu LM
Integr Cancer Ther; 2012 Mar; 11(1):37-47. PubMed ID: 21382954
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor effect of the extract from qingyihuaji formula on pancreatic cancer by down-regulating Notch-4 and Jagged-1.
Xu Y; Zhu F; Xu S; Liu L
J Tradit Chin Med; 2015 Feb; 35(1):77-83. PubMed ID: 25842732
[TBL] [Abstract][Full Text] [Related]
7. Qingyihuaji Formula Inhibits Pancreatic Cancer and Prolongs Survival by Downregulating Hes-1 and Hey-1.
Xu Y; Xu S; Cai Y; Liu L
Evid Based Complement Alternat Med; 2015; 2015():145016. PubMed ID: 26783407
[TBL] [Abstract][Full Text] [Related]
8. Nanog Predicts Poor Prognosis in Human Pancreatic Cancer and Is Downregulated by QingyihuaJi Formula in Pancreatic Cancer Stem Cells.
Gao S; Pan Y; Song L; Dong L; Weng LI; Wang P; Hua Y; Chen Z; Liu L
Evid Based Complement Alternat Med; 2016; 2016():7028289. PubMed ID: 27829864
[TBL] [Abstract][Full Text] [Related]
9. [Effect of Qingyi Huaji formula for inhibition of pancreatic cancer cell growth through down-regulating Ski expression].
Wang P; Liu LM; Chen Z
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Sep; 30(9):942-5. PubMed ID: 21179734
[TBL] [Abstract][Full Text] [Related]
10. Targeting cancer-related inflammation: Chinese herbal medicine inhibits epithelial-to-mesenchymal transition in pancreatic cancer.
Zhang J; Wang P; Ouyang H; Yin J; Liu A; Ma C; Liu L
PLoS One; 2013; 8(7):e70334. PubMed ID: 23922983
[TBL] [Abstract][Full Text] [Related]
11. Effects of Qingyi Huaji decoction on serum levels of interleukin-6, interleukin-8 and tumor necrosis factor-alpha in nude mice bearing pancreatic tumors.
Ouyang HQ; Liu LM; Chen Z; Luo JM; Yu EX
Zhong Xi Yi Jie He Xue Bao; 2010 Jul; 8(7):655-61. PubMed ID: 20619142
[TBL] [Abstract][Full Text] [Related]
12. Effects of baicalein on pancreatic cancer stem cells via modulation of sonic Hedgehog pathway.
Song L; Chen X; Wang P; Gao S; Qu C; Liu L
Acta Biochim Biophys Sin (Shanghai); 2018 Jun; 50(6):586-596. PubMed ID: 29697746
[TBL] [Abstract][Full Text] [Related]
13. Babaodan Capsule () combined with Qingyi Huaji Formula () in advanced pancreatic cancer-a feasibility study.
Song LB; Gao S; Zhang AQ; Qian X; Liu LM
Chin J Integr Med; 2017 Dec; 23(12):937-942. PubMed ID: 28664246
[TBL] [Abstract][Full Text] [Related]
14. Increased EphB2 expression predicts cholangiocarcinoma metastasis.
Khansaard W; Techasen A; Namwat N; Yongvanit P; Khuntikeo N; Puapairoj A; Loilome W
Tumour Biol; 2014 Oct; 35(10):10031-41. PubMed ID: 25012246
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the B-type Eph and ephrin genes correlates with progression and pain in human pancreatic cancer.
Lu Z; Zhang Y; Li Z; Yu S; Zhao G; Li M; Wang Z; Wang Q; Yang Y
Oncol Lett; 2012 Jun; 3(6):1207-1212. PubMed ID: 22783419
[TBL] [Abstract][Full Text] [Related]
16. Cucurmosin induces the apoptosis of human pancreatic cancer CFPAC-1 cells by inactivating the PDGFR-β signalling pathway.
Xie J; Wang C; Zhang B; Yang A; Yin Q; Huang H; Chen M
Pharmacol Rep; 2013; 65(3):682-8. PubMed ID: 23950591
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro.
Qin Y; Ertl T; Cai RZ; Halmos G; Schally AV
Cancer Res; 1994 Feb; 54(4):1035-41. PubMed ID: 8313359
[TBL] [Abstract][Full Text] [Related]
18. EphB-EphrinB interaction controls odontogenic/osteogenic differentiation with calcium hydroxide.
Wang X; Jong G; Lin LM; Shimizu E
J Endod; 2013 Oct; 39(10):1256-60. PubMed ID: 24041387
[TBL] [Abstract][Full Text] [Related]
19. The Roles of EphB2 in Cancer.
Liu W; Yu C; Li J; Fang J
Front Cell Dev Biol; 2022; 10():788587. PubMed ID: 35223830
[TBL] [Abstract][Full Text] [Related]
20. EPH/ephrin profile and EPHB2 expression predicts patient survival in breast cancer.
Husa AM; Magić Ž; Larsson M; Fornander T; Pérez-Tenorio G
Oncotarget; 2016 Apr; 7(16):21362-80. PubMed ID: 26870995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
